0002095129-25-000001.txt : 20251104 0002095129-25-000001.hdr.sgml : 20251104 20251103181207 ACCESSION NUMBER: 0002095129-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251104 DATE AS OF CHANGE: 20251103 EFFECTIVENESS DATE: 20251104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tempero Bio, Inc. CENTRAL INDEX KEY: 0002095129 ORGANIZATION NAME: EIN: 853213394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562889 FILM NUMBER: 251445617 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 BUSINESS PHONE: 5102272102 MAIL ADDRESS: STREET 1: 1111 BROADWAY, SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 D 1 primary_doc.xml X0708 D LIVE 0002095129 Tempero Bio, Inc. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 5102272101 DELAWARE None None Corporation true 2020 Paul Johnson c/o Tempero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Executive Officer Director Joshua Gertsman c/o Tempero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Joseph Jimenez c/o Tempero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Francisco Gimenez c/o Tempero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Director Christian Klee c/o Tempero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Executive Officer Julie Shah c/o Termpero Bio, Inc. 1111 Broadway, Suite 1300 Oakland CA CALIFORNIA 94607 Executive Officer Ricardo Dolmetsch c/o Tempero Bio, Inc. 1111 Brodway, Suite 1300 Oakland CA CALIFORNIA 94607 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-10-30 false true true Offering of Series B-1 Preferred Stock and Series B-2 Preferred Stock (collectively "Preferred Stock") and the underlying shares of Common Stock issuable upon conversion of Preferred Stock. false 0 76958457 76958457 0 false 23 0 0 0 false Tempero Bio, Inc. /s/ Christian Klee Christian Klee Chief Financial Officer 2025-11-03